StockData
Xeris Biopharma Holdings, Inc. logo

Xeris Biopharma Holdings, Inc. (XERS) stock

XERSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$16.80+0.10 (+0.60%)

Close on Nov 17, 2026Market cap $3.06BP/E –Yield –

How the market prices Xeris Biopharma

Each ratio against its own distribution since 2021, from month-end prices and the figures reported at the time

Xeris Biopharma trades at 9.1× its earnings, against a median of 3.3× since 2021 — dearer than 96% of the months in between.

The shaded bar covers the 5th to 95th percentile of month-end values since 2021, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to sales since 2021

Median 3.3×, today 9.1×

What Xeris Biopharma keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Gross margin86.6%vs 52.8%
Operating margin10.9%vs -42.9%
EBITDA margin11.3%vs -29.3%
Net margin-5.12%vs -39.9%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on assets-4.60%vs -40.7%
Return on invested capital22.1%vs -32.4%
Return on capital employed16.5%vs -38.7%

How hard the assets work

Revenue per dollar of assets0.90vs 0.39
Inventory turns a year0.61vs 2.68
Revenue per employee$771.07Kvs $405.05K
Profit per employee-$39.46Kvs -$704.12K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Borrowings exceed cash by $130.84M, or 3.4 times a year of EBITDA. That is 4.1% of the $3.19B it would cost to buy the business outright.

Total debt$252.59M
Cash and short-term investments$121.75M
EBITDA, trailing twelve months$37.93M

Leverage and liquidity

Debt to EBITDA6.66vs 3.42
Net debt to EBITDA3.45vs 2.33
Current ratio1.45vs 3.28
Quick ratio0.95vs 2.37

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

3.33
DistressGrey zoneSafe

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

8 of 9 tests passed

Beneish M-Score

Eight variables that flag accounts shaped to look better than they are.

-2.59
No flagManipulation risk

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Earnings yield-0.56%vs -22.8%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 17, 2026

$5.2552-week low52-week high$16.98
200-day50-day20-day$16.80

The close sits 98% of the way up the 52-week range, 1.1% below the high.

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

86
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

XERSS&P 500
PeriodXERSS&P 500DifferenceXERS per yearS&P 500 per year
1 month+62.9%-4.0%+67.0 pts
3 months+97.2%-5.0%+102.2 pts
Year to date+114.0%+8.2%+105.8 pts
1 year+131.4%+11.2%+120.2 pts
3 years+849.2%+68.5%+780.7 pts+111.7%+19.0%
5 years+585.7%+67.3%+518.4 pts+47.0%+10.8%

How much it moves

Volatility, 1 year56.8%vs 80.5%
Volume against its 90-day average1.08vs 0.86

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

9M XERS shares were sold short on Oct 30, 2026, up 11.9% from the previous report, or 5.20% of the shares available to trade. At recent volumes it would take 4.3 days to buy them back. Over the last 20 sessions, 27.2% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Short interest as a share of the float5.20%vs 8.89%
Short interest as a share of all shares4.93%vs 6.30%
Days of volume to buy it back4.34vs 5.13

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20268,986,870+11.9%2,072,2274.3
Oct 15, 20268,027,654+11.5%2,463,1883.3
Sep 30, 20267,202,379-10.6%4,146,0961.7
Sep 15, 20268,058,977+0.2%1,667,3164.8
Aug 31, 20268,041,258-7.9%1,471,1495.5
Aug 14, 20268,728,856-5.3%1,965,8904.4
Jul 31, 20269,221,405-8.5%1,366,1746.8
Jul 15, 202610,078,469-21.0%2,299,4634.4
Jun 30, 202612,760,034-0.4%2,343,8475.4
Jun 15, 202612,810,046+2.4%1,746,6047.3
May 29, 202612,514,253+1.2%1,328,8989.4
May 15, 202612,364,664-22.2%2,131,9915.8

Every measure, in full

79 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 1, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 17, 2026

Valuation ratiosIndustry

Market Cap
$3.06B
$254.69M
Enterprise Value
$3.19B
$130.88M
PS Ratio
9.13
3.66
P/OCF Ratio
54.11
13.24

Enterprise valuationIndustry

EV / Sales
9.52
2.38
EV / EBITDA
84.21
16.00
EV / EBIT
87.28
18.86

Share statisticsIndustry

Shares Change (YoY)
21.8%
11.0%
Shares Change (QoQ)
0.60%
0.57%
Float
173M
49M
Shares Held by Insiders
5.16%
11.3%
Shares Held by Institutions
59.4%
56.3%

Short sellingIndustry

Short Interest
9M
–
Short Interest Change
11.9%
-0.80%
Short % of Float
5.20%
8.89%
Short % of Shares Outstanding
4.93%
6.30%
Days to Cover
4.34
5.13

Stock price statisticsIndustry

52-Week High
$16.98
–
52-Week Low
$5.25
–
20-Day Moving Average
$12.94
–
50-Day Moving Average
$10.73
–
200-Day Moving Average
$7.92
–
Average True Range (14)
$0.72
–
Price Change (1 Week)
6.13%
-7.83%
Price Change (1 Month)
53.4%
-6.48%
Price Change (3 Months)
91.3%
-26.6%
Price Change (6 Months)
183.8%
-22.2%
Price Change (YTD)
114.0%
-25.6%
Price Change (1 Year)
134.0%
-23.8%
Price Change (3 Years)
849.2%
-32.9%
Price Change (5 Years)
602.9%
-77.3%
Average Volume (10 Days)
5M
–
Average Volume (20 Days)
3M
–
Average Volume (90 Days)
2M
–
Relative Volume
1.08
0.86
Relative Strength Index (14)
85.8
40.3
Volatility (1 Year)
56.8%
80.5%

MarginsIndustry

Gross Margin
86.6%
52.8%
Operating Margin
10.9%
-42.9%
Profit Margin
-5.12%
-39.9%
EBITDA Margin
11.3%
-29.3%

Returns on capitalIndustry

Return on Assets (ROA)
-4.60%
-40.7%
Return on Invested Capital (ROIC)
22.1%
-32.4%
Return on Capital Employed (ROCE)
16.5%
-38.7%

Financial positionIndustry

Current Ratio
1.45
3.28
Quick Ratio
0.95
2.37
Debt / EBITDA
6.66
3.42
Net Debt / EBITDA
3.45
2.33
Interest Coverage
1.30
-6.20

GrowthIndustry

Revenue Growth (YoY)
36.3%
5.68%
Revenue Growth (3Y CAGR)
38.3%
2.25%
Revenue Growth (5Y CAGR)
70.2%
6.41%

EfficiencyIndustry

Asset Turnover
0.90
0.39
Inventory Turnover
0.61
2.68
Revenue Per Employee
$771.07K
$405.05K
Profits Per Employee
-$39.46K
-$704.12K
Employee Count
435
75

Income statement (TTM)Industry

Revenue
$335.41M
$58.79M
Gross Profit
$290.39M
$103.58M
Operating Income
$36.59M
-$21.49M
Net Income
-$17.17M
-$22.47M
EBITDA
$37.93M
-$17.14M
EPS (Diluted)
-$0.12
-$0.83

Balance sheetIndustry

Total Debt
$252.59M
$114.91M
Net Cash (Debt)
-$130.84M
$15.31M
Net Cash Per Share
-$0.72
$0.72
Equity (Book Value)
-$9.73M
$49.40M
Book Value Per Share
-$0.05
$1.45
Tangible Book Value
-$115.25M
$23.58M
Working Capital
$85.19M
$74.34M

Cash flow (TTM)Industry

Operating Cash Flow
$56.61M
-$12.17M

Dividends and yieldsIndustry

Earnings Yield
-0.56%
-22.8%

Taxes and interestIndustry

Interest Expense
$28.25M
$3.07M
Income Tax
$0
$77.43K

Scores and fair valueIndustry

Altman Z-Score
3.33
0.12
Piotroski F-Score
8
4
Beneish M-Score
-2.59
-2.62

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?